Pharma Services May 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Pharma Services – Development industry totaled nine mergers & acquisitions and five financings during the month of May
• In terms of M&A, the Clinical Services sector was the most active this month, with 7 M&A transactions; while in terms of financing Laboratory Services was the most active with 3 financings
• Total disclosed M&A value was $2.4 million, while financing totaled $283.5 million
• The largest disclosed M&A transaction this month was the $2.4 million acquisition of BASi Gaithersburg by Bioanalytical Systems, while the largest financing this month was $200 million raised by Tempus Labs
• M&A and financings in the United States accounted for 67% and 60% of total transactions this month, up 11% and 20%, respectively
• M&A activity this month includes acquisitions by Genstar Capital, ICON, WuXi Clinical, Caris Life Sciences and Great Point Partners
• Crosstree acted as the financial advisor to Genstar on its acquisition of Advarra